High Authority for Health

What High Authority for Health does

High Authority for Health (Haute Autorité de Santé, HAS) is an independent French public administrative authority (autorité administrative indépendante), established in 2004 and headquartered at 5 avenue du Stade de France, Saint-Denis La Plaine. It operates the national machinery for health technology assessment in France: HAS evaluates drugs, medical devices, and health technologies for reimbursement decisions via its CNEDiMTS committee, produces clinical practice guidelines, certifies healthcare establishments, accredits physicians in high-risk specialties, and publishes quality and safety indicators (IQSS). Its outputs are used by public payers, healthcare professionals, healthcare establishments, patients, and industry, giving HAS a structurally diverse stakeholder base across the French health system.

HAS's product surface centers on a small set of named platforms and programs: Qualiscope (a public portal for healthcare establishment quality), BQSS (scope-of-care analysis), IQSS (quality and safety indicators), CNEDiMTS (medical device evaluation), GRAAL, ADOPIHAD, the healthcare establishment certification scheme, and physician accreditation. The underlying technology stack is built on JALIOS JCMS as the content management substrate, with Apache Tomcat and OpenJDK as the runtime layer, and generative AI tooling layered onto translation, reformulation, summarization, document analysis, and infographic generation — all gated by mandatory human validation before publication. Open-data publishing via data.gouv.fr and APIs for publication metadata extend the surface outward.

HAS is funded through French government budget appropriation rather than commercial revenue; it does not sell products or services to customers in the conventional sense. It pursues its mission through statutory evaluation work and through partnerships with bodies such as EUNETHA (European HTA network), PASQ (patient safety and quality), STC (chlordecone clinical toxicology), and EHESP (degree program). Direction of publication rests with Pr Lionel Collet, and the 2023-2028 strategic roadmap formalizes priorities including digital transformation and AI integration.

Name

High Authority for Health

Legal name

Haute Autorité de santé

Website

https://has-sante.fr

Company type

Private

Founded year

2004

Operating status

Operating

Short description

The Haute Autorité de Santé (HAS) is a French independent public authority that evaluates health technologies, certifies healthcare establishments, accredits physicians, and publishes clinical guidelines and quality indicators used by payers, providers, and patients across the French health system.

Ownership category

akta.pro rank

Product category

Healthcare Quality & Regulatory Services

NAICS

Management, Scientific, and Technical Consulting Services (5416)

SIC

Hospital & Medical Service Plans (6324)

akta.pro primary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Health technology assessment
• Healthcare quality certification
• Clinical practice guidelines
• Drug reimbursement evaluation
• Medical device assessment

Headquarters

HQ city

Saint-denis

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Distribution channels3 records

Marketing channels6 records

Core offering

The Haute Autorité de Santé (HAS) is a French independent public administrative authority that evaluates health technologies, drugs and medical devices for reimbursement decisions, certifies healthcare and medico-social establishments, accredits physicians in high-risk specialties, develops evidence-based clinical practice guidelines, and publishes quality and safety of care indicators. It distributes its evaluations, guidelines, certification results and open data free of charge to professionals, healthcare establishments, patients and the healthcare industry.

Product overview

HAS operates as a comprehensive health technology assessment and quality assurance authority offering multiple interconnected products and services. The core portfolio includes: Qualiscope (quality information platform for healthcare establishments and ESSMS), EDN (document evaluation system), GRAAL (reading groups), and ADOPIHAD (hospitalization at home decision support). Quality assessment products include certification of health establishments, physician accreditation programs, and quality and safety indicators (IQSS). Health technology assessment is delivered through drug evaluation (SMR/ASMR), medical device assessment via CNEDiMTS, and health technology assessment reports. The BQSS database aggregates quality and safety data, while open data access is provided through a public API and data.gouv.fr publishing.

Differentiator

Problem solved

Functional benefit

Products and services

• Qualiscope

Quantifiable outcome

• Certification of health establishments every 4 years, covering both public and private facilities
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• Société de Toxicologie Clinique (STC)coreStrategic or Co-development Partner · 1 January 2026HAS developed clinical toxicology recommendations in partnership with the Société de Toxicologie Clinique (STC), notably for chlordécone exposure guidelines.
• EUNETHA (European Network for Health Technology Assessment)coreOthersHAS participates in EUNETHA, the European network for health technology assessment, contributing to international collaboration on HTA methodology and assessments.
• PASQ (Partenariat d'Amélioration de la Qualité)coreOthersHAS collaborates with PASQ, a quality improvement partnership organization.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Agence nationale de sécurité du médicament (ANSM): French national medicines safety agency. Operates in the same French regulatory ecosystem as HAS, with an overlapping but distinct remit (marketing authorisation and pharmacovigilance vs HAS's clinical benefit and certification).

Direct peers

• Institute for Quality and Efficiency in Health Care (IQWiG): Germany's federal HTA agency. Comparable to HAS in producing benefit assessments that feed G-BA reimbursement decisions, with a similar methodology and publication discipline.
• Belgian Health Care Knowledge Centre (KCE): Belgian federal HTA and health services research center. Comparable to HAS in producing technology assessments, clinical guidelines and good clinical practice reports for federal reimbursement decisions.
• Zorginstituut Nederland (ZIN): Dutch national HTA and quality institute. Comparable to HAS in administering reimbursement package advice, quality standards and indicators for curative and long-term care.
• Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU): Swedish national HTA agency. Comparable to HAS in producing independent assessments of health technologies and methods for clinical practice and social services.
• Canadian Agency for Drugs and Technologies in Health (CADTH): Canada's national HTA and reimbursement recommendation body. Direct peer in scope: drug and medical-device reviews, plus guidelines and optimal-use recommendations for provincial payers.
• National Institute for Health and Care Excellence (NICE): UK statutory HTA and guidelines body. Most direct international analogue to HAS: technology appraisals, clinical guidelines, quality standards, and a central role in NHS reimbursement decisions.

Emerging players

• Institute for Clinical and Economic Review (ICER): Independent US HTA organization producing cost-effectiveness reviews that influence payer coverage. Comparable to HAS's CNEDiMTS medical-device assessments and SMR/ASMR drug opinions, but private-sector funded.

Others

• European Network for Health Technology Assessment (EUnetHTA): Joint HTA secretariat of EU member-state agencies including HAS. HAS's core international partnership hub, now underlying the EU HTA Regulation's joint clinical assessment framework.

Broad incumbents

• Agency for Healthcare Research and Quality (AHRQ): US federal agency for healthcare quality and safety research. Broader US scope but overlapping function on quality indicators, evidence synthesis and patient safety — analogous to HAS's quality-and-safety remit.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/has_sante
• YouTubeyoutube.com/HauteAutoritedeSante
• Facebookfacebook.com/pages/Haute-Autorit%C3%A9-de-Sant%C3%A9/162499997206968
• LinkedInlinkedin.com/company/haute-autorite-de-sante

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about High Authority for Health